ProCE Banner Activity

Delivering High Quality IBD Care to South Asians (With Slide Notes in Hindi)

Slideset

South Asian gastroenterologists and a South Asian registered dietitian provide the healthcare provider’s perspective from India and the United States on the unique challenges and cultural barriers to IBD care that affect South Asian patients, from Clinical Care options (CCO) and South Asian IBD Alliance (SAIA), with slide notes available in Hindi.

Released: October 04, 2023

Share

Faculty

Tauseef Ali

Tauseef Ali, MD, FACG, AGAF

Medical Executive Director
SSM Health Crohn’s and Colitis Center
Oklahoma City, Oklahoma

Tina Aswani-Omprakash

Tina Aswani-Omprakash, MPH

President and Co-Founder, South Asian IBD Alliance
Mount Sinai Department of Medicine
Dr. Henry D. Janowitz Division of Gastroenterology
New York, New York

Sumit Bhatia

Sumit Bhatia, MBBS, MD, DM

Senior Consultant 
Gastroenterology and Hepatology 
Paras Hospitals 
Gurgaon, Haryana, India 

Parakkal Deepak

Parakkal Deepak, MBBS, MS, FACG 

Vice-President, South Asian IBD Alliance
Director of Clinical and Translational Research
Associate Professor of Medicine 
Division of Gastroenterology
John T. Milliken Department of Medicine 
Washington University School of Medicine in St. Louis 
St. Louis, MO, USA

Neil Nandi

Neil Nandi, MD, FACP

Associate Professor Of Clinical Medicine
Division of Gastroenterology and Hepatology
University of Pennsylvania, Perelman School Of Medicine
Philadelphia, Pennsylvania

Neha D. Shah

Neha D. Shah, MPH, RD, CNSC, CHES

Senior Dietitian 
Colitis and Crohn's Disease Center 
University of California, San Francisco 
San Francisco, California 

Provided by

Provided by Clinical Care Options, LLC in partnership with South Asian IBD Alliance

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb, Hollister, Inc., Janssen Pharmaceutical Companies, Lilly, Takeda Pharmaceuticals U.S.A., Inc.

Bristol Myers Squibb

Hollister, Inc.

Janssen Pharmaceutical Companies

Lilly

Takeda Pharmaceuticals U.S.A., Inc.